What Researchers Did
This single-center, prospective, feasibility study included 34 subjects with various wounds to evaluate fluorescence angiography's ability to assess tissue perfusion changes during hyperbaric oxygen therapy (HBOT).
What They Found
A total of 34 subjects participated, with 22 receiving at least 10 hyperbaric oxygen therapy (HBOT) sessions. Fluorescence angiography successfully provided real-time visualization and objective assessment of changes in local tissue perfusion throughout the HBOT course.
What This Means for Canadian Patients
This study suggests that fluorescence angiography could potentially help doctors monitor how well hyperbaric oxygen therapy is improving blood flow to their wounds. This real-time feedback might lead to more personalized and effective treatment plans for complex, non-healing wounds.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
This was a single-center feasibility study with a limited sample size, which restricts the generalizability of its findings.